HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ichiro Tokimitsu Selected Research

Diglycerides

3/2011The short-term effect of diacylglycerol oil consumption on total and dietary fat utilization in overweight women.
3/2009The effects of diacylglycerol oil on fat oxidation and energy expenditure in humans and animals.
5/2008Effects of a single and short-term ingestion of diacylglycerol on fat oxidation in rats.
4/2008Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study.
1/2008One-year ad libitum consumption of diacylglycerol oil as part of a regular diet results in modest weight loss in comparison with consumption of a triacylglycerol control oil in overweight Japanese subjects.
12/2007Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance.
5/2007Dietary diacylglycerol induces the regression of atherosclerosis in rabbits.
1/2007WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia.
1/2007Effects of phytosterols in diacylglycerol as part of diet therapy on hyperlipidemia in children.
4/2006Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ichiro Tokimitsu Research Topics

Disease

18Obesity
09/2018 - 08/2002
14Body Weight (Weight, Body)
03/2010 - 10/2002
5Insulin Resistance
09/2018 - 05/2005
5Hypertension (High Blood Pressure)
11/2009 - 09/2005
5Hyperlipidemias (Hyperlipidemia)
12/2007 - 03/2005
4Type 2 Diabetes Mellitus (MODY)
02/2009 - 01/2006
3Overweight
03/2011 - 01/2008
3Weight Loss (Weight Reduction)
02/2009 - 12/2002
3Cardiovascular Diseases (Cardiovascular Disease)
06/2008 - 06/2007
3Glucose Intolerance
12/2007 - 09/2005
3Atherosclerosis
05/2007 - 07/2003
3Hypercholesterolemia
01/2007 - 01/2006
2Hyperglycemia
09/2018 - 01/2018
2Inflammation (Inflammations)
09/2018 - 12/2002
2Hypertriglyceridemia
01/2008 - 01/2006
2Thrombosis (Thrombus)
01/2006 - 01/2006
1Metabolic Diseases (Metabolic Disease)
09/2018
1Muscular Atrophy (Muscle Atrophy)
01/2018
1Sarcopenia
04/2013
1Hyperemia
01/2010
1Hyperinsulinism (Hyperinsulinemia)
05/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2007
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2007
1Hypertrophy
06/2006
1Renal Insufficiency (Renal Failure)
02/2006
1Diabetes Mellitus
09/2005
1Fatty Liver
04/2005
1Erythema
12/2002
1Experimental Arthritis
12/2002

Drug/Important Bio-Agent (IBA)

23DiglyceridesIBA
03/2011 - 08/2002
11Triglycerides (Triacylglycerol)IBA
04/2008 - 08/2002
9TeaIBA
09/2018 - 01/2004
6Catechin (Z 7300)IBA
04/2013 - 06/2007
5CholesterolIBA
05/2007 - 07/2003
5Phytosterols (Plant Sterols)IBA
01/2007 - 07/2003
4Insulin (Novolin)FDA Link
01/2018 - 12/2007
4Fatty Acids (Saturated Fatty Acids)IBA
03/2010 - 08/2002
4CoffeeFDA Link
11/2009 - 09/2005
4LipidsIBA
05/2007 - 07/2003
3Glucose (Dextrose)FDA LinkGeneric
05/2009 - 09/2005
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2018 - 01/2018
2Chemotactic FactorsIBA
09/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
09/2018 - 03/2009
2PolyphenolsIBA
01/2018 - 01/2008
2Dietary Fats (Dietary Fat)IBA
03/2011 - 10/2002
2LeptinIBA
04/2008 - 06/2006
2AcidsIBA
01/2008 - 06/2006
23-nitrotyrosineIBA
01/2008 - 06/2006
2hydroxyhydroquinone (hydroxyquinol)IBA
01/2008 - 04/2006
2Lipoproteins (Lipoprotein)IBA
12/2007 - 01/2007
2oxidized low density lipoproteinIBA
01/2007 - 01/2006
2NADPH Oxidases (NAD(P)H oxidase)IBA
06/2006 - 04/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2006 - 04/2006
2EstersIBA
02/2006 - 01/2006
2alpha-Linolenic Acid (Linolenic Acid)IBA
04/2005 - 10/2002
1epicatechin gallateIBA
09/2018
1Selenoprotein PIBA
09/2018
1FatsIBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1CarbohydratesIBA
03/2011
1Starch (Cornstarch)IBA
03/2010
1Resistant StarchIBA
03/2010
1Antihypertensive Agents (Antihypertensives)IBA
11/2009
1IncretinsIBA
05/2009
1Hormones (Hormone)IBA
05/2009
1Peptides (Polypeptides)IBA
05/2009
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2009
1Therapeutic UsesIBA
02/2009
1Hemoglobin AIBA
02/2009
1SolutionsIBA
01/2009
1Fish OilsIBA
12/2007
1LDL CholesterolIBA
06/2007
1Lipoprotein(a)IBA
01/2007
1EnzymesIBA
11/2006
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2006
1Chlorogenic AcidIBA
06/2006
1Superoxides (Superoxide)IBA
06/2006
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2006
1NADP (NADPH)IBA
06/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2006
1Acetylcholine (Acetylcholine Chloride)FDA Link
06/2006
1Messenger RNA (mRNA)IBA
04/2006
1Sucrose (Saccharose)IBA
04/2006
1EmulsionsIBA
03/2006
1Apolipoproteins E (ApoE)IBA
01/2006
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2006
1HDL CholesterolIBA
01/2006
1Unsaturated Dietary FatsIBA
07/2003
1Indomethacin (Indometacin)FDA LinkGeneric
12/2002
1CarrageenanIBA
12/2002
1OilsIBA
10/2002

Therapy/Procedure

3Diet Therapy (Therapy, Diet)
01/2007 - 12/2002
1Glycemic Control
02/2009
1Therapeutics
02/2009
1Drug Therapy (Chemotherapy)
01/2007
1Lasers (Laser)
01/2006